Gene · 1737
Papers2,650
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,650
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cuproptosis in spinal cord injury: emerging mechanisms and immunological relevance. | Ann Med | 2026 | 41883033 | PubTator, text mining | PubMed |
| Hsa_circ_0000711 can serve as a novel biomarker for primary biliary cholangitis by promoting disease progression through the regulation of miR-185-5p and NFATc3. | RNA Biol | 2026 | 41879109 | PubTator, text mining | PubMed |
| SNHG7 interacts with PCBP2 to promote CDKN2A expression and modulate cuproptosis in colorectal cancer. | Transl Oncol | 2026 | 41875809 | PubTator, text mining | PubMed |
| MT2A-Mediated Regulation of Cuproptosis in Human Dental Pulp Cells Modulates Macrophage M1 Polarization in Pulpitis. | Int Dent J | 2026 | 41863975 | PubTator, text mining | PubMed |
| Effects of a peer-led educational intervention based on the theory of planned behavior on alcohol use intention and behavior among secondary school students in Northeast Ethiopia. | PLoS One | 2026 | 41860826 | PubTator, text mining | PubMed |
| The role of copper and cuproptosis in digestive system cancers: novel therapeutic strategies and mechanistic insights. | Cancer Biol Ther | 2026 | 41837409 | PubTator, text mining | PubMed |
| Pyruvate metabolism enzyme Dlat induces mitochondria protein hyperacetylation to limit fatty acid oxidation in the HFpEF heart. | Nat Commun | 2026 | 41826295 | PubTator, text mining | PubMed |
| Microrobotic copper-rich electrochemical interfacing for targeted cancer theranostics in the gut. | Sci Adv | 2026 | 41824583 | PubTator, text mining | PubMed |
| The EZH2-NEAT1 epigenetic axis promotes cuproptosis sensitivity and modulates cancer cell migration in colorectal cancer. | J Gastrointest Oncol | 2026 | 41816582 | PubTator, text mining | PubMed |
| Paeoniflorin-Copper-Coordinated Nanoparticles Targeting Dual Organelles Induce Lung Cancer Apoptosis. | Mol Pharm | 2026 | 41810719 | PubTator, text mining | PubMed |
| Electric vehicle adoption intentions among UK residents parking in shared and public spaces. | Transportation (Amst) | 2026 | 41810329 | PubTator, text mining | PubMed |
| Dual cut-offs and beyond: Expanding the role of transient elastography in primary biliary cholangitis. | World J Gastroenterol | 2026 | 41809882 | PubTator, text mining | PubMed |
| Adipokine profiles reflect metabolic dysfunction but not fibrosis in patients with primary biliary cholangitis. | World J Hepatol | 2026 | 41809476 | PubTator, text mining | PubMed |
| XN@CuO/HA nanobipyramids trigger FOXO1-GADD45G-mediated cuproptosis and synergy with anti-PD-1 for lung cancer therapy. | Mater Today Bio | 2026 | 41809377 | PubTator, text mining | PubMed |
| Metabolic reprogramming in cancer: dysregulation of glucose, lipid, and amino acid pathways and therapeutic opportunities. | Mol Biomed | 2026 | 41806079 | PubTator, text mining | PubMed |
| Alternative Polyadenylation Signatures Distinguish Maladaptive Right Ventricular Remodeling in Pulmonary Hypertension: Implications for RNA-Based Diagnostics and Therapeutics. | Br J Biomed Sci | 2026 | 41799857 | PubTator, text mining | PubMed |
| Copper-doped COF triggered bioorthogonal synergistic cancer therapy through apoptosis and cuproptosis. | Bioorg Chem | 2026 | 41795342 | PubTator, text mining | PubMed |
| Targeting regulated cell death pathways in lung cancer: mechanisms, therapeutic strategies, and clinical translation. | Front Immunol | 2026 | 41789093 | PubTator, text mining | PubMed |
| Copper Homeostasis and Cuproptosis in Neurological Disorders. | Drug Des Devel Ther | 2026 | 41783572 | PubTator, text mining | PubMed |
| The PBC Ireland patient registry: study protocol for a national platform on primary biliary cholangitis. | Ther Adv Rare Dis | 2026 | 41783366 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1737/papers?page=5